U.S. Life Sciences Stock News

If you are wondering whether Pfizer is quietly setting up to be a value play rather than just a defensive healthcare name, you are not alone, and the recent numbers give us plenty to unpack. Despite a tough few years, with the stock still down about 42.8% over three years and 13.4% over five, it has started to stabilize. It has posted a modest 0.4% gain over the last week, 1.1% over the last month, and a 9.1% rise over the past year, even though it remains down 3.0% year to date. Recent news...

Bath & Body Works (BBWI) just put investors through a rough quarter, missing earnings, trimming its full year outlook, and sending the stock into a sharp slide that has value hunters paying closer attention. See our latest analysis for Bath & Body Works. Those shaky results land on top of a tough stretch, with the share price at $19.94 and a year to date share price return of about negative 47 percent. The one year total shareholder return of roughly negative 45 percent shows how prolonged...

Many investors are wondering if FactSet Research Systems is a bargain or a value trap at around $291 a share. With the recent slide in the share price, they are trying to figure out whether expectations have finally reset to a sensible level. Over the last week the stock is up 4.5%, adding to a 7.4% gain over the past month. However, this comes against a backdrop of a steep drawdown, with shares down 38.8% year to date and 39.6% over the last year. Investors have been digesting a mixed macro...

If you have been wondering whether Badger Meter is still worth the price tag at around $182 per share, you are not alone. This article is designed to unpack that question clearly. The stock is down about 20.3% over the past year and 13.8% year to date, even though it is still up 65.2% over three years and 112.2% over five years. This combination often signals shifting expectations rather than a broken business. Recent attention on smart water infrastructure, sustainability initiatives, and...

Wondering if Lowe's Companies at around $248 a share is a bargain or just fairly priced? Here is a closer look at what the numbers say about where value might be hiding. The stock has inched up about 0.8% over the last week and 5.4% over the past month, but is roughly flat year to date and still about 4.0% lower than a year ago, even after gaining 26.6% over three years and 66.3% over five. Those moves come as investors continue to weigh the long term demand for home improvement against...

Alaska Air Group has launched ticket sales for a new year-round, nonstop Seattle–London Heathrow route on Boeing 787-9 aircraft starting May 21, 2026, while also cutting its fourth-quarter 2025 earnings guidance due to IT outages, government shutdown-related disruptions, and higher fuel costs. These developments highlight how Alaska Air is simultaneously pursuing long-haul international growth from its Seattle hub and confronting operational and legal challenges, including an investor...

Donaldson Company (DCI) just delivered another upside surprise, pairing record quarterly sales and earnings with a guidance bump that signals management sees this momentum carrying into 2026, not just flashing temporarily. See our latest analysis for Donaldson Company. The latest beat and guidance hike build on a strong run, with a roughly 38% year to date share price return and five year total shareholder return of about 77% pointing to steadily building momentum as investors re-rate its...

BeOne Medicines (NasdaqGS:ONC) just put fresh sonrotoclax data in front of hematology specialists at ASH. The story is squarely about durability, high risk disease coverage, and a realistic path toward FDA accelerated approval. See our latest analysis for BeOne Medicines. Despite a choppy last month, with a 30 day share price return of minus 6.6 percent, BeOne Medicines still sports a powerful year to date share price gain of roughly 74 percent and a one year total shareholder return near 78...

Wondering if Progress Software is quietly becoming a value opportunity, or a trap that just looks cheap on the surface? This breakdown is designed to give you a clear, no nonsense view of what you are really buying at today’s price. The stock has bounced about 4.1% over the last week and 4.7% over the last month, but it is still down roughly 30.3% year to date and 35.2% over the past year. That tells us sentiment has been weak even as short term buyers start to nibble again. Those moves sit...

The latest move in Advance Auto Parts (AAP) came right after the Federal Reserve cut rates again and signaled ongoing support for the economy, which sparked a broad retail rally that pulled the stock higher. See our latest analysis for Advance Auto Parts. That macro driven bounce comes after a choppy stretch, with a 90 day share price return of minus 20.95% but a 12.14% one year total shareholder return, which hints that early turnaround believers are being rewarded while short term momentum...

Gap (GPS) is back in the spotlight after long time insider William Sydney Fisher unloaded 400,000 shares, a move that briefly knocked the stock while investors weighed it against the company’s improving fundamentals. See our latest analysis for Gap. Despite the brief shock from the insider sale, Gap’s 1 month share price return of 11.32 percent and 3 year total shareholder return of 129.54 percent suggest momentum is still building as supply chain upgrades, fresh collaborations and a stronger...

Earlier this month, Sunrun Inc. filed a US$693.55 million shelf registration to issue 38,854,154 common shares linked to employee stock plans. This sizable registration revived concerns about future dilution at a time when Sunrun is already contending with flat sales and cash burn. Next, we’ll examine how this large employee-related share registration could reshape Sunrun’s investment narrative around growth, funding, and dilution. The end of cancer? These 29 emerging AI stocks are...

Gevo (GEVO) is back on traders’ radar after CFO Oluwagbemileke Yusuf Agiri sold a sizable block of shares, just as the company reported Q3 revenue growth and a new $26 million carbon management partnership. See our latest analysis for Gevo. The insider sale lands against a backdrop of improving sentiment, with Gevo’s share price up 14.35 percent over the past month and 43.11 percent over the past quarter. Its one-year total shareholder return of 58.28 percent indicates that momentum is...

BridgeBio Pharma (BBIO) just delivered a quarter where revenue topped expectations, thanks largely to strong U.S. demand for its heart drug Attruby, even as the company remained in the red. See our latest analysis for BridgeBio Pharma. Those upbeat Attruby numbers and the recent insider share sale have landed as the stock keeps grinding higher, with a roughly 11 percent 1 month share price return feeding into a powerful 1 year total shareholder return above 160 percent. This is a sign that...

Avient (AVNT) just doubled down on its long term playbook by cutting costs, raising prices where it can, and closing the DSM protective materials deal that brings the Dyneema brand into its portfolio. See our latest analysis for Avient. The market reaction has been cautious so far, with the share price at $31.51 and a 1 month share price return of 5.7 percent. However, a year to date share price return of negative 21.7 percent and a 1 year total shareholder return of negative 32.4 percent...

Wondering if Zebra Technologies is quietly turning into a value opportunity after a rough patch in the tech space? This article will walk through whether the current price really makes sense. The stock has bounced about 4% over the last week and 7.2% in the past month, even though it is still down roughly 29% year to date and about 33% over the last year, a pattern that often signals shifting sentiment rather than a simple trend. Investors have been reacting to ongoing developments around...

Trip.com Group (TCOM) just beat expectations in its fiscal Q3 2025 report, with international bookings and inbound travel surging, and the stock reaction reflects growing confidence in its cross border travel recovery story. See our latest analysis for Trip.com Group. Despite today’s muted 1 day share price return, Trip.com’s 8.3% year to date share price gain and triple digit three and five year total shareholder returns suggest momentum is still broadly constructive as cross border demand...

Onto Innovation recently took part in a KeyBanc virtual meeting on 9 December, where management outlined its current strategic initiatives and market outlook in semiconductor process control metrology and defect inspection. This engagement drew attention to the company’s balance-sheet strength and consistent revenue growth, reinforcing interest in how its high-performance inspection systems fit into broader semiconductor trends. Next, we'll explore how Onto Innovation’s KeyBanc discussion of...

Many investors are asking whether Carlyle Group at around $60 is still a smart buy or if most of the upside is already reflected in the price, and that is exactly what we are going to unpack here. The stock has climbed 6.9% over the last week, 11.7% over the past month, and is now up 18.6% year to date, adding to an increase of 123.1% over three years and 126.2% over five years. Recent headlines have focused on Carlyle sharpening its emphasis on core private equity, credit, and...

Nextpower (NXT) just put some fresh weight behind its growth story by opening a new Remote Monitoring Center in Nashville and teaming up with MSS Steel Tubes to double its Southeast steel fabrication capacity. See our latest analysis for Nextpower. That expansion story is landing in a market that has already been warming up to Nextpower, with the latest share price at $93.43 after a 1 day share price return of 4.52 percent and a powerful year to date share price return of 136.53 percent. The...

Huntington Ingalls Industries (HII) has quietly pushed to a fresh high, with the stock up about 19% over the past 3 months and roughly 74% year to date, drawing renewed attention from defense investors. See our latest analysis for Huntington Ingalls Industries. That surge sits on top of an already strong run, with the latest share price at $326.72 and solid defense spending tailwinds helping deliver a powerful year to date share price return and a hefty multi year total shareholder return...

Old National Bancorp recently announced that longtime Commercial Banking CEO Jim Sandgren will retire in April 2026, marking the end of a nearly 35-year career during which he helped shape the bank into a US$71.00 billion regional institution across 10 states. His retirement underscores an upcoming leadership transition in a core business line at a time when Old National’s commercial strategy and community engagement remain central to its identity. We’ll now examine how the Fed’s latest rate...

Chewy (CHWY) just posted its Q3 2026 numbers, with revenue of about $3.1 billion and net income of $59.2 million translating into basic EPS of roughly $0.14 as investors parse how the pet retailer is holding up in a tougher consumer backdrop. The company has seen quarterly revenue move from $2.88 billion in Q3 2025 to around $3.1 billion across 2026 so far, while basic EPS shifted from $0.01 a year ago to roughly the mid-$0.14 range in each quarter, setting up this print as a test of how...

In recent weeks, State Street Investment Management and Galaxy Asset Management launched plans for the State Street Galaxy Onchain Liquidity Sweep Fund (SWEEP), backed by US$200 million in seed capital from Ondo Finance, while ETF inflows surpassed US$1.25 billion this year, supported by active fixed-income strategies. Together, these developments highlight how State Street is pairing new tokenized cash-management solutions with strong ETF demand to reinforce its core asset-servicing and...